In conclusion, pretreatment with Tec attenuated hepatic inflammation, ameliorated liver injury, and reduced the mortality in mice with FHF by inhibiting inflammation via the TLR4/MAPK and TLR4/NF‐κB pathways and by promoting autophagy. Here, TLR4 is linked to TNF receptor 1-associated periodic fever syndrome.